rs104886040
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_001360.3(DHCR7):āc.321G>Cā(p.Gln107His) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000602 in 1,610,294 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001360.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DHCR7 | NM_001360.3 | c.321G>C | p.Gln107His | missense_variant, splice_region_variant | 4/9 | ENST00000355527.8 | NP_001351.2 | |
DHCR7 | NM_001163817.2 | c.321G>C | p.Gln107His | missense_variant, splice_region_variant | 4/9 | NP_001157289.1 | ||
DHCR7 | XM_011544777.3 | c.321G>C | p.Gln107His | missense_variant, splice_region_variant | 4/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DHCR7 | ENST00000355527.8 | c.321G>C | p.Gln107His | missense_variant, splice_region_variant | 4/9 | 1 | NM_001360.3 | ENSP00000347717.4 | ||
DHCR7 | ENST00000685320.1 | c.-265G>C | splice_region_variant | 3/8 | ENSP00000509319.1 | |||||
DHCR7 | ENST00000685320.1 | c.-265G>C | 5_prime_UTR_variant | 3/8 | ENSP00000509319.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152146Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245468Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132764
GnomAD4 exome AF: 0.0000645 AC: 94AN: 1458148Hom.: 0 Cov.: 30 AF XY: 0.0000621 AC XY: 45AN XY: 724948
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74314
ClinVar
Submissions by phenotype
Smith-Lemli-Opitz syndrome Pathogenic:2Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 10, 2022 | This sequence change affects codon 107 of the DHCR7 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the DHCR7 protein. RNA analysis indicates that this variant induces altered splicing and likely results in the gain of 12 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is present in population databases (rs104886040, gnomAD 0.01%). This variant has been observed in individual(s) with Smith-Lemli-Opitz syndrome (PMID: 15896653). ClinVar contains an entry for this variant (Variation ID: 813426). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in the activation of a cryptic splice site in intron 4 (PMID: 10995508). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 20, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 17, 2024 | Variant summary: DHCR7 c.321G>C (p.Gln107His) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. This variant also locates in the exonic splice region of exon 4. Several computational tools predict a significant impact on normal splicing: Three predict the variant weakens the canonical 5' donor site. One predict the variant abolishes the canonical 5' splicing donor site. At least one publication reports experimental evidence that this variant affects mRNA splicing by inserting 36 intronic nucleotides and results in insertion of an in-frame 12 amino acids (Krakowiak_2000). The variant allele was found at a frequency of 1.2e-05 in 245468 control chromosomes, predominantly at a frequency of 0.00013 within the African or African-American subpopulation in the gnomAD database. c.321G>C has been reported in the literature in at-least two individuals affected with Smith-Lemli-Opitz Syndrome (Krakowiak_2000, Ginat_2004, Wassif_2005). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 1.3% of normal activity in untransformed fibroblasts from the patient carying the current variant and another missense p.C444Y (Ginat_2004). The following publications have been ascertained in the context of this evaluation (PMID: 15464432, 10995508, 15896653). ClinVar contains an entry for this variant (Variation ID: 813426). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at